'Lack of checks' on drugs after launch
US health regulators lack sufficient resources to monitor the safety of new drugs once they are on the market, a former head of the Food and Drug Administration. David Kessler said the biggest threat
US health regulators lack sufficient resources to monitor the safety of new drugs once they are on the market, a former head of the Food and Drug Administration. David Kessler said the biggest threat